Bread Financial Holdings, Inc. (BFH): what the price assumes

boothcheck covers Bread Financial Holdings, Inc. (BFH) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/BFH

Headline

FieldValue
TickerBFH
CompanyBread Financial Holdings, Inc.
Sector / IndustryFinancial Services
Current price$108.42/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Multiple paid3x operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 14.4% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.29σ
cohort percentile (of 18 peers)6
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.66x4justifies
Earnings0.30x4justifies
Relative0.53x4justifies
Growth0.29x3justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.3%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$2087.890.05xyesFCF base $2.2B, growth 3% (input: historical growth), terminal g 2.5%, WACC 5.3%, 5yr projection
DCF Exit MultipleGrowth$380.150.29xyesExit EV/EBITDA: 157.4x / 159.4x / 161.4x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$159.840.68xyesP/E 12x (static sector reference · 2026-04), scenarios: 10.1x / 12.0x / 13.9x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$140.390.77xyesBV/sh $76.97, ROE (TTM) 16.9%, ke 9.3%
Two-Stage Excess ReturnAsset$187.140.58xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$98.601.10xyesRev $4.1B, growth 3% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$147.120.74xyesEPS $12.26, growth 2% (input: historical EPS growth), PEG=4.17 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$0.0110842.00xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.08B × (1−26%) / WACC 5.3% → EPV (no growth) (excluded from median)
Residual IncomeAsset$188.510.58xyesBV $76.97 + 5yr PV of (ROE (TTM) 16.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$145.710.74xyes√(22.5 × EPS $12.26 × BVPS $76.97) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings$367.580.29xyesFCF $2186.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$353.070.31xyesSBC-adj FCF $2.13B (FCF $2.19B − SBC $0.06B) capitalized at Kₑ
Ben Graham FormulaEarnings$395.590.27xyesEPS $12.26 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$286.040.38xyesRevenue $4.12B × sector P/S 3.0x
PEG Fair ValueRelative$459.750.24xyesEPS $12.26 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$132.540.82xyesEPS $12.26 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-3.6%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The most persuasive thing about this company right now is not the card book. It is what has been done to the liabilities sitting behind it. Over the course of 2025 the company redeemed senior notes, retired subordinated paper, issued preferred stock, and completed "the repurchases of 100% of our outstanding convertible senior notes", instruments that carried a 4.25% coupon and, more importantly, a claim on the equity if the shares recovered. Removing a convertible is not a financing decision so much as a statement: management would rather pay cash than let anyone else buy the upside cheaply. The 7.000% senior notes issued in 2020 have been worked down the same way, with $400 million redeemed in January 2024.

Capital was returned at the same time, which is the harder trick. Common equity tier 1 capital began 2025 near 2.47 billion dollars, took in 518 million dollars of net income available to common shareholders, and paid out 42 million dollars in dividends and 313 million dollars of share repurchases while still ending the year in a stronger regulatory position. Share count has fallen about 3.6% a year over the four years to March 2026. A lender that shrinks its own equity base while its regulatory capital ratio holds is a lender whose earnings genuinely exceed what the balance sheet needs.

The credit numbers underneath have turned in the right direction. In the June 2026 quarter the net loss rate improved by 90 basis points to 6.98% and the delinquency rate by 48 basis points to 5.25%. For a private label card book those are the only two numbers that matter in the short run, because everything else in the income statement is downstream of them. The company itself says as much, describing how it "closely monitor[s] Delinquency rates and Net principal loss rates, which reflect, among other factors, our underwriting, the inherent credit risk in our portfolio and the success of our collection and recovery efforts".

The business model deserves more credit than the sector multiple gives it. This is not a bank competing for the same prime customer as everyone else. The partner does the customer acquisition, the brand does the marketing, and the lender collects a merchant discount fee from the partner "to compensate us for all or part of the forgone interest income associated with promotional financing". That fee stream is a genuine second source of revenue that a standalone card issuer does not have, and it arrives whether or not the customer revolves.

Against the cohort, the growth is unremarkable and the price is not. Revenue has been growing at a low single-digit pace, similar to Synchrony (SYF) at 3.1% and SLM (SLM) at 2.3%, and well behind LendingClub (LC) at 25.4% and Enova (ENVA) at 17.5%. But every standard way of valuing the equity lands above the current price, not below it. Trailing earnings run 12.26 dollars a share, and stated book value 76.97 dollars a share. Buyers are paying under nine times earnings and comfortably under one and a half times book for a business earning a 16.9% trailing return on that equity. The bull case does not require a re-rating story. It requires the credit trend of the past two quarters to persist.

Bear Case

Watch where the capital goes, because it says what management believes and what it is willing to risk. In 2025 the company earned 518 million dollars available to common shareholders and handed 313 million of it back through buybacks, roughly seven and a half times what it paid in dividends. In the June 2026 quarter alone it repurchased 2.8 million shares for $241 million while issuing $135 million of preferred stock at an 8.875% rate. Read those two transactions next to each other and the arithmetic is worth pausing on: the company is retiring common equity that costs nothing in cash and replacing part of it with preferred equity that costs almost nine percent a year. That is a defensible optimisation when the shares are cheap and a costly one if the credit cycle turns and the preferred coupon still has to be paid.

The capital being returned is also the capital that absorbs losses. This is an unsecured consumer lender whose net loss rate, even after a good quarter, runs near seven percent of principal. A book with that loss rate is not a mistake; it is the design, and the pricing compensates for it. But it means the equity is the first-loss piece of a portfolio whose performance is set by the employment rate and by how much of their income the customers of mid-market retailers have left over. Buying back stock through the improving half of a credit cycle removes the cushion right before the part of the cycle where cushions matter.

Then there is who the partners are. The programme list runs to Saks Fifth Avenue, Signet, Victoria's Secret, Ulta, Academy Sports and Raymour & Flanigan, and every one of those is a discretionary retailer whose own sales are cyclical. The partner concentration risk is explicit in the company's own risk factors, which name "the concentration of our business in" a limited number of relationships as a stated exposure. Partner agreements come up for renewal, and when one does the negotiation happens with a counterparty that knows exactly how much of the lender's revenue depends on it. Losing a large programme does not damage a quarter. It removes a business line.

Funding is the third pressure. Deposits here are gathered online through a direct-banking platform rather than through branches, and the company concedes that "Competition among direct banks is intense because online banking provides customers the" ability to move money at will. Rate-shopping deposits are the least loyal funding in banking. The securitization channel that supplements them carries a mandated five percent risk retention, so the company cannot fully sell the risk it originates even when it wants to.

None of which makes the shares expensive. That has to be said plainly, because the price already sits below what every standard valuation approach reaches, and below the level even a five percent annual decline in operating profit would support. The bear case is therefore not about the multiple. It is that the market applies a 14.5% cost of capital to this business for a reason, and the reason is that a three times multiple on a peak-quality credit year is not the same thing as a three times multiple on a normal one. The cheapness is the compensation for the cyclicality, not a mistake in spite of it.

Valuation

Something unusual is going on in the valuation here, and it is worth naming before anything else: every family of method lands above the current price. Book value plus profitability, peer multiples, capitalized earnings, and forward projections all centre higher than $104.32, some of them by a considerable distance. That configuration is rare. It normally means either that the market disagrees with the inputs those methods use, or that it is applying a discount to the whole earnings stream that the methods do not.

In this case it is the second, and the machinery makes it visible. The discount rate the market appears to be applying to this business runs near 14.5%, roughly double what a stable consumer staple carries, because the shares move about one and three quarters times as much as the market does. At that discount rate the price works out to about 3.2 times a year of company-wide operating profit, low enough that it sits below what even a five percent annual decline in that profit would support. The market is not forecasting a collapse. It is refusing to pay much for earnings it does not trust to repeat.

Whether that refusal is right turns on one number, and it is not a valuation number. The net loss rate came down 90 basis points to 6.98% in the June quarter and the delinquency rate to 5.25%, and full-year loss guidance was tightened to a range of 7.0% to 7.1% from a prior expectation nearer the low end of 7.2% to 7.4%. Every dollar of improvement in that rate falls almost directly to pre-tax income, which is why a lender's multiple moves so violently with credit and so little with revenue.

A caution on the methods that land furthest above the price. Several of them capitalize free cash flow, and for a lender free cash flow is largely an artefact of whether the loan book grew or shrank in the period rather than a measure of profitability. The readings worth weighting are the ones anchored on equity and earnings: trailing earnings near 12.26 dollars a share, and a stated book value of 76.97 dollars a share supporting a 16.9% trailing return on equity. Those are the numbers a buyer is actually underwriting.

The solvency frame for a lender is capital and payout capacity rather than coverage or net debt, and on that frame the position has been improving while the share count shrinks about 3.6% a year. What the price is really asking is a question about the next recession rather than the next quarter, and no method in the set can answer it.

Catalysts

The most recent hard information arrived on July 23, 2026, when the company reported second-quarter net income of $146 million and diluted earnings of $3.55 a share. The result beat expectations on stronger credit sales, but the more consequential lines were the credit metrics: the net loss rate improved 90 basis points to 6.98% and the delinquency rate 48 basis points to 5.25%, both better year over year and better than the prior quarter.

Guidance moved with the data in two places. Full-year net loss rate expectations were tightened to 7.0% to 7.1%, from a prior expectation near the low end of a 7.2% to 7.4% range, and full-year average credit card and other loan growth guidance was lifted to low-to-mid single digits from low single digits. A lender raising loan growth guidance while lowering expected losses is claiming both volume and quality at once, which is the combination that has to hold for the current numbers to be a trend rather than a favourable quarter.

Capital actions continued alongside. The company repurchased 2.8 million shares for $241 million during the quarter and issued $135 million of preferred stock carrying an 8.875% rate. The pace of buyback relative to quarterly earnings is the thing to track from here, because it is the clearest signal available of how management reads its own loss outlook. The next test is the September-quarter print, where the question is whether the delinquency improvement carries through a seasonal period that historically works against it.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2025 Form 10-K, debt note · Bread Financial Q2 2026 earnings release, July 23, 2026

View the full interactive BFH report on boothcheck